5.19
-0.95%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Jointown Pharmaceutical Group Co
Its shares trade on Shanghai under the ticker 600998.SS. It has been listed since 2 November 2010. In the fiscal year to 31 December 2025, it reported revenue of CN¥161.39bn and net income of CN¥2.25bn. At that date it held total assets of CN¥116.41bn and shareholders' equity of CN¥28.55bn.
Jointown Pharmaceutical Group Co., Ltd. engages in the manufacture and distribution of pharmaceuticals, traditional Chinese medicine, and medical equipment. The company is headquartered in Wuhan, Hubei. The company went IPO on 2010-11-02. The firm is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Company’s products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The firm mainly provides services to direct sales or franchise stores through its retailing businesses.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 2 Nov 2010
- Employees
- 29,338
- Website
- jztey.com ↗
Leadership
Pay as last reported
- Mr. Changyun LiuChairman of the Board, since 2017CN¥1.2m
- Mr. Yichang LiuBusiness President, Vice Chairman of the Board, since 2017CN¥92,200
- Mr. Yihua GongVice Chairman of the Board, General Manager, since 2008CN¥820,600
- Mr. Dengpan LiuVice Chairman of the Board, since 2008CN¥1.6m
- Mr. Zhaonian LiuVice Chairman of the Board, since 2008CN¥823,600
- Mr. Xiaoyi XiaChief Financial OfficerCN¥306,700
- Mr. Wei HeVice President, Director, since 2022CN¥603,100
- Mr. Zhifeng LiuDeputy General Manager, Secretary of the BoardCN¥391,900
- Mr. Weijun ChenDeputy General ManagerCN¥2.7m
- Ms. Lei GuoDeputy General ManagerCN¥407,200
- Ms. Ming QuanDeputy General ManagerCN¥505,200
- Mr. Qibing WangDeputy General ManagerCN¥1.6m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 74
- Environment
- 99
- Social
- 86
- Governance
- 36
- Direct emissions (scope 1)
- 36,924.21 t
- Energy emissions (scope 2)
- 11,005.2 t
- Women in the workforce
- 46.81%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Jointown Pharmaceutical Group Co Ltd possesses several key strengths that contribute to its success in the market. These strengths include:
- Despite its strengths, Jointown Pharmaceutical Group Co Ltd also faces certain weaknesses that pose challenges to its overall performance:
- Jointown Pharmaceutical Group Co Ltd has several potential opportunities that can be leveraged to further enhance its market position:
- Jointown Pharmaceutical Group Co Ltd faces several threats that may impact its performance and market position:
Weaknesses
- Despite its strengths, Jointown Pharmaceutical Group Co Ltd also faces certain weaknesses that pose challenges to its overall performance:
- Jointown Pharmaceutical Group Co Ltd has several potential opportunities that can be leveraged to further enhance its market position:
- Jointown Pharmaceutical Group Co Ltd faces several threats that may impact its performance and market position:
Opportunities
- Jointown Pharmaceutical Group Co Ltd has several potential opportunities that can be leveraged to further enhance its market position:
- Jointown Pharmaceutical Group Co Ltd faces several threats that may impact its performance and market position:
Threats
- Jointown Pharmaceutical Group Co Ltd faces several threats that may impact its performance and market position:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.